Exact Mass: 468.1388708
Exact Mass Matches: 468.1388708
Found 500 metabolites which its exact mass value is equals to given mass value 468.1388708
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
104-1
104-2
Jangomolide
Constituent of Flacourtia jangomas (paniala) and Limonia acidissima (wood apple). Jangomolide is found in herbs and spices, beverages, and fruits. Jangomolide is found in beverages. Jangomolide is a constituent of Flacourtia jangomas (paniala) and Limonia acidissima (wood apple).
Dukunolide D
Dukunolide D is found in fruits. Dukunolide D is a constituent of Lansium domesticum (langsat) Constituent of Lansium domesticum (langsat). Dukunolide D is found in fruits.
Silymonin
Silymonin is found in coffee and coffee products. Silymonin is a constituent of Silybum marianum (milk thistle)
2-({5-Chloro-2-[(2-Methoxy-4-Morpholin-4-Ylphenyl)amino]pyrimidin-4-Yl}amino)-N-Methylbenzamide
C23H25ClN6O3 (468.16765699999996)
Apocynin A
Prim-O-glucosylcimifugin
C22H28O11 (468.16315380000003)
simfibrate
C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent > C98150 - Fibrate Antilipidemic Agent C - Cardiovascular system > C10 - Lipid modifying agents > C10A - Lipid modifying agents, plain > C10AB - Fibrates
Epigallocatechin 3-caffeate
Epigallocatechin 3-caffeate is a member of the class of compounds known as epigallocatechins. Epigallocatechins are compounds containing epigallocatechin or a derivative. Epigallocatechin is a flavan-3-ol containing a benzopyran-3,5,7-triol linked to a 3,4,5-hydroxyphenyl moiety. Thus, epigallocatechin 3-caffeate is considered to be a flavonoid lipid molecule. Epigallocatechin 3-caffeate is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Epigallocatechin 3-caffeate can be found in tea, which makes epigallocatechin 3-caffeate a potential biomarker for the consumption of this food product.
Cimifugin 7-glucoside
C22H28O11 (468.16315380000003)
PRIM-O-GLUCOSYLCIMIFUGIN is an organic heterotricyclic compound and an oxacycle. Prim-O-glucosylcimifugin is a natural product found in Ostericum grosseserratum, Saposhnikovia divaricata, and other organisms with data available. Prim-O-glucosylcimifugin exerts anti-inflammatory effects through the inhibition of iNOS and COX-2 expression by through regulating JAK2/STAT3 signaling. Prim-O-glucosylcimifugin exerts anti-inflammatory effects through the inhibition of iNOS and COX-2 expression by through regulating JAK2/STAT3 signaling.
Artoindonesianin B
Apocynin A
dichamanetin
A natural product found in Piper sarmentosum.
erythbigenol A
Erythbigenone A
Catechin-4-ol 3-O-beta-D-galactopyranoside
Leucodelphinidin 3-O-alpha-L-rhamnopyranoside
Apocynin C
N-Fructosyl gamma-glutamyl-S-(1-propenyl)cysteine sulfoxide
Annotation level-3
Gyrophoric acid
Origin: Microbe, Carboxylic acids
(2-methoxy-5-hydroxymethyl-phenyl)-1-O-beta-D-(6-O-galloyl)-glucopyranoside|2-methoxy-5-hydroxymethyl-phenyl-1-O-(6-galloyl)-beta-D-glucopyranoside|2-Methoxy-5-hydroxymethyl-phenyl-1-O-(6-galloyl)-??-D-glucopyranoside
3-carboxy-6,7-dihydroxy-1-(3,4-dihydroxyphenyl)-naphthalene-9,5-O-shikimic acid ester
4-(2-{5-[(1,6-dioxaspiro[4.5]dec-3-en-2-ylidene)methyl]-2-thienyl}-2,5-dihydro-5-[(2-thienyl)methylene]-2-furyl)butanol|4-<2-<5-<(1,6-dioxaspiro<4.5>dec-3-en-2-ylidene)methyl>-2-thienyl>-2,5-dihydro-5-<(2-thienyl)methylene>-2-furyl>butanol
3-(4-acetoxy-3-methoxyphenyl)-2-<4-acetoxy-6-(3-acetoxyprop-2-enyl)-3-methoxy>-prop-2-ene
1,2,3,4-Tetrahydro-4,6,9-trihydroxy-2,3-epoxy-1,2-biphenazine-4-carboxylic acid
(4-Methoxycarbonylphenyl-2,3,4-tri-O-acetyl-beta-D-glucopyranosid)-uronsaeure-methylester|<4-Methoxycarbonylphenyl-2,3,4-tri-O-acetyl-beta-D-glucopyranosid>-uronsaeure-methylester|Methyl-<4-methoxy-carbonyl-phenyl-2,3,4-tri-O-acetyl-beta-D-glucopyranosid>-uronat
7-O-alpha-L-rhamnosyl-8-[2-oxo-2H-1-benzopyran-7-(hydroxy)-6-yl]-2H-1-benzopyran-2-one|7-O-alpha-L-rhamnosyl-8-[2-oxo-2H-1-benzopyran-7-(hydroxy)-6-yl]-2H-1-benzopyran-2-one|daphjamilin
3-(4-acetoxy-3-methoxyphenyl)-2-<4-acetoxy-6-(3-acetoxyprop-2-enyl)-3-methoxy>-prop-1-ene
3,4-dihydroxyphenethyl alcohol 4-O-beta-D-(6-O-galloyl)-glucopyranoside|3,4-dihydroxyphenethyl alcohol 4-O-beta-D-(6-O-galloyl)glucopyranoside|4-O-(6-O-Galloyl-beta-D-glucopyranoside)-2-(3,4-Dihydroxyphenyl)ethanol|4-O-(6-O-Gulloyl-??-D-glucopuranoside)-2-(3,4-Dihydroxyphenyl)ethanol
3-Hydroxy,6-O-(3,4,5-trihydroxybenzoyl)-Salidroside|6-O-(3,4,5-Trihydroxybenzoyl)-2-(3,4-Dihydroxyphenyl)ethyl beta-D-glucopy-ranoside
1-O-angeloylglycerol 2-O-beta-D-apiofuranosyl-(1->6)-beta-D-glucopyranoside|everlastoside G
2-[(2S)-2,3-dihydro-7-hydroxy-2-(1-hydroxy-1,5-dimethyl-4-hexen-1-yl)-4-benzofuranyl]-3-methoxy-5,7-dihydroxy-4H-[1]benzopyran-4-one|nigrasin J
(4S,8R,9S)-4-(3,4-dihydroxyphenyl)-8-(3,4,5-trihydroxyphenyl)-3,4,9,10-tetrahydro-5,9-dihydroxy-2H,8H-benzo[1,2-b:3,4-b]dipyran-2-one|sclerophynin A
3-(8,9,9-Trimethoxy-9H-benzo[de][1,6]naphthyridine-3-yl)-8-methoxy-9H-benzo[de][1,6]naphthyridine-9-one
1-(3,4-dihydroxyphenyl)-6-(syringoyl)-beta-D-glucopyranose|dunnianoside G
6-(8,9,9-Trimethoxy-9H-benzo[de][1,6]naphthyridine-3-yl)-8-methoxy-9H-benzo[de][1,6]naphthyridine-9-one
threo-1-(4-hydroxy-2-methoxyphenyl)-2-(2,4-dihydroxy-phenyl)-1,3-propanediol-4-O-?-D-glucopyranoside
C22H28O11 (468.16315380000003)
1,2-bis(4-hydroxy-3-methoxyphenyl)-1,3-propandiol 4-O-beta-D-glucopyranoside|1-(4-O-beta-glucosyl-2-hydroxyphenyl)-2-(2-hydroxy-4-methoxyphenyl)-1,3-propanediol|myriophylloside G|threo-1,2-bis(4-hydroxy-3-methoxyphenyl)-1,3-propandiol 4-O-beta-D-glucopyranoside|threo-2,3-bis(4-hydroxy-3-methoxyphenyl)-3-ethoxypropan-1-ol
C22H28O11 (468.16315380000003)
1beta,9alpha-di(3-furanoyloxy)-2,8-dioxo-3-enedihydro-beta-agarofuran
6-O-beta-D-glucopyranosyl-5-methoxy-7-phenyl-3H-benzo[de]isochromen-1-one|haemodorose
6-O-(6?-O-phydroxybenzoyl)-beta-D-glucopyranosyl-des-p-hydroxybenzoyl-3-deoxycatalpin
C22H28O11 (468.16315380000003)
1,8-dihydroxy-3,7-dimethoxy-4-O-[3-methyl-4-(3-methyl-2H,5H-2-oxofuran-5-yl)-2-butenyl]xanthone
beta,2,3,4,4,6-hexahydroxy-alpha-(alpha-L-rhamnopyranosyl)dihydrochalcone
2,9-Diacetoxy-3,10-dimethoxy-13-(acetoxymethyl)-6,12-methano-5,6,7,12-tetrahydrodibenzo[a,d]cyclooctene
7-(1,1-dimethylallyl)-2,3-dihydro-3-(4-hydroxy-3,5-dimethoxyphenyl)-10-methoxy-2-methyl-6H-1,4,5-trioxaphenanthren-6-one|antidesmanin A
longicornuol A|threo-1-{9-hydroxy-3-[2-(3-hydroxyphenyl)ethyl]-1,8,10-trimethoxy-6H-benzo[c]chromen-6-yl}ethane-1,2-diol
5-hydroxyaiphanol|5-{(E)-2-[(2R,3R)-8-hydroxy-3-(4-hydroxy-3,5-dimethoxyphenyl)-2-(hydroxymethyl)-2,3-dihydrobenzo[b][1,4]dioxin-6-yl]vinyl}benzene-1,3-diol
13-hydroxykompasinol A|{(3/3a-trans,3a/8a-cis,8/8a-trans)-5,7-dihydroxy-3-(3,4,5-trihydroxyphenyl)-8-(4-hydroxy-3,5-dimethoxyphenyl)-3,3a,8,8a-tetrahydro-1H-2-oxacyclopenta[a]indene}
Tyr Ala Thr Asp
C20H28N4O9 (468.18561980000004)
Thr Ser Phe Asp
C20H28N4O9 (468.18561980000004)
Jangomolide
Jangomolide is a steroid lactone.
(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(3-hydroxy-4-methoxy-2,5-diphenylphenoxy)oxane-2-carboxylic acid
Prim-O-glucosylcimifugin
C22H28O11 (468.16315380000003)
Prim-O-glucosylcimifugin exerts anti-inflammatory effects through the inhibition of iNOS and COX-2 expression by through regulating JAK2/STAT3 signaling. Prim-O-glucosylcimifugin exerts anti-inflammatory effects through the inhibition of iNOS and COX-2 expression by through regulating JAK2/STAT3 signaling.
6-(furan-3-yl)-13-hydroxy-5,12,16,16-tetramethyl-7,10,17-trioxahexacyclo[13.3.3.0¹,¹⁵.0²,¹².0⁵,¹¹.0⁹,¹¹]henicos-19-ene-8,14,21-trione
6-(furan-3-yl)-13-hydroxy-5,12,16,16-tetramethyl-7,10,17-trioxahexacyclo[13.3.3.0¹,¹⁵.0²,¹².0⁵,¹¹.0⁹,¹¹]henicos-19-ene-8,14,21-trione_major
6-(furan-3-yl)-13-hydroxy-5,12,16,16-tetramethyl-7,10,17-trioxahexacyclo[13.3.3.0¹,¹?.0²,¹².0?,¹¹.0?,¹¹]henicos-19-ene-8,14,21-trione
Ala Cys Glu Phe
Ala Cys Phe Glu
Ala Asp Thr Tyr
C20H28N4O9 (468.18561980000004)
Ala Asp Tyr Thr
C20H28N4O9 (468.18561980000004)
Ala Glu Cys Phe
Ala Glu Phe Cys
Ala Glu Ser Tyr
C20H28N4O9 (468.18561980000004)
Ala Glu Tyr Ser
C20H28N4O9 (468.18561980000004)
Ala Phe Cys Glu
Ala Phe Glu Cys
Ala Ser Glu Tyr
C20H28N4O9 (468.18561980000004)
Ala Ser Tyr Glu
C20H28N4O9 (468.18561980000004)
Ala Thr Asp Tyr
C20H28N4O9 (468.18561980000004)
Ala Thr Tyr Asp
C20H28N4O9 (468.18561980000004)
Ala Tyr Asp Thr
C20H28N4O9 (468.18561980000004)
Ala Tyr Glu Ser
C20H28N4O9 (468.18561980000004)
Ala Tyr Ser Glu
C20H28N4O9 (468.18561980000004)
Ala Tyr Thr Asp
C20H28N4O9 (468.18561980000004)
Cys Ala Glu Phe
Cys Ala Phe Glu
Cys Cys Asp Glu
C15H24N4O9S2 (468.09846539999995)
Cys Cys Glu Asp
C15H24N4O9S2 (468.09846539999995)
Cys Cys Phe Pro
Cys Cys Ile Met
C17H32N4O5S3 (468.15347420000006)
Cys Cys Leu Met
C17H32N4O5S3 (468.15347420000006)
Cys Cys Met Ile
C17H32N4O5S3 (468.15347420000006)
Cys Cys Met Leu
C17H32N4O5S3 (468.15347420000006)
Cys Cys Pro Phe
Cys Asp Cys Glu
C15H24N4O9S2 (468.09846539999995)
Cys Asp Glu Cys
C15H24N4O9S2 (468.09846539999995)
Cys Asp Met Thr
Cys Asp Thr Met
Cys Glu Ala Phe
Cys Glu Cys Asp
C15H24N4O9S2 (468.09846539999995)
Cys Glu Asp Cys
C15H24N4O9S2 (468.09846539999995)
Cys Glu Phe Ala
Cys Glu Met Ser
Cys Glu Ser Met
Cys Phe Ala Glu
Cys Phe Cys Pro
Cys Phe Glu Ala
Cys Phe Pro Cys
Cys Ile Cys Met
C17H32N4O5S3 (468.15347420000006)
Cys Ile Met Cys
C17H32N4O5S3 (468.15347420000006)
Cys Leu Cys Met
C17H32N4O5S3 (468.15347420000006)
Cys Leu Met Cys
C17H32N4O5S3 (468.15347420000006)
Cys Met Cys Ile
C17H32N4O5S3 (468.15347420000006)
Cys Met Cys Leu
C17H32N4O5S3 (468.15347420000006)
Cys Met Asp Thr
Cys Met Glu Ser
Cys Met Ile Cys
C17H32N4O5S3 (468.15347420000006)
Cys Met Leu Cys
C17H32N4O5S3 (468.15347420000006)
Cys Met Ser Glu
Cys Met Thr Asp
Cys Pro Cys Phe
Cys Pro Phe Cys
Cys Pro Ser Tyr
Cys Pro Tyr Ser
Cys Ser Glu Met
Cys Ser Met Glu
Cys Ser Pro Tyr
Cys Ser Tyr Pro
Cys Thr Asp Met
Cys Thr Met Asp
Cys Tyr Pro Ser
Cys Tyr Ser Pro
Asp Ala Thr Tyr
C20H28N4O9 (468.18561980000004)
Asp Ala Tyr Thr
C20H28N4O9 (468.18561980000004)
Asp Cys Cys Glu
C15H24N4O9S2 (468.09846539999995)
Asp Cys Glu Cys
C15H24N4O9S2 (468.09846539999995)
Asp Cys Met Thr
Asp Cys Thr Met
Asp Asp Gly Tyr
C19H24N4O10 (468.14923639999995)
Asp Asp Tyr Gly
C19H24N4O10 (468.14923639999995)
Asp Glu Cys Cys
C15H24N4O9S2 (468.09846539999995)
Asp Phe Gly Met
Asp Phe Met Gly
Asp Phe Ser Thr
C20H28N4O9 (468.18561980000004)
Asp Phe Thr Ser
C20H28N4O9 (468.18561980000004)
Asp Gly Asp Tyr
C19H24N4O10 (468.14923639999995)
Asp Gly Phe Met
Asp Gly Met Phe
Asp Gly Tyr Asp
C19H24N4O10 (468.14923639999995)
Asp Met Cys Thr
Asp Met Phe Gly
Asp Met Gly Phe
Asp Met Thr Cys
Asp Ser Phe Thr
C20H28N4O9 (468.18561980000004)
Asp Ser Thr Phe
C20H28N4O9 (468.18561980000004)
Asp Thr Ala Tyr
C20H28N4O9 (468.18561980000004)
Asp Thr Cys Met
Asp Thr Phe Ser
C20H28N4O9 (468.18561980000004)
Asp Thr Met Cys
Asp Thr Ser Phe
C20H28N4O9 (468.18561980000004)
Asp Thr Tyr Ala
C20H28N4O9 (468.18561980000004)
Asp Tyr Ala Thr
C20H28N4O9 (468.18561980000004)
Asp Tyr Asp Gly
C19H24N4O10 (468.14923639999995)
Asp Tyr Gly Asp
C19H24N4O10 (468.14923639999995)
Asp Tyr Thr Ala
C20H28N4O9 (468.18561980000004)
Glu Ala Cys Phe
Glu Ala Phe Cys
Glu Ala Ser Tyr
C20H28N4O9 (468.18561980000004)
Glu Ala Tyr Ser
C20H28N4O9 (468.18561980000004)
Glu Cys Ala Phe
Glu Cys Cys Asp
C15H24N4O9S2 (468.09846539999995)
Glu Cys Asp Cys
C15H24N4O9S2 (468.09846539999995)
Glu Cys Phe Ala
Glu Cys Met Ser
Glu Cys Ser Met
Glu Asp Cys Cys
C15H24N4O9S2 (468.09846539999995)
Glu Phe Ala Cys
Glu Phe Cys Ala
Glu Phe Ser Ser
C20H28N4O9 (468.18561980000004)
Glu Gly Thr Tyr
C20H28N4O9 (468.18561980000004)
Glu Gly Tyr Thr
C20H28N4O9 (468.18561980000004)
Glu Met Cys Ser
Glu Met Ser Cys
Glu Ser Ala Tyr
C20H28N4O9 (468.18561980000004)
Glu Ser Cys Met
Glu Ser Phe Ser
C20H28N4O9 (468.18561980000004)
Glu Ser Met Cys
Glu Ser Ser Phe
C20H28N4O9 (468.18561980000004)
Glu Ser Tyr Ala
C20H28N4O9 (468.18561980000004)
Glu Thr Gly Tyr
C20H28N4O9 (468.18561980000004)
Phe Ala Cys Glu
Phe Ala Glu Cys
Phe Cys Ala Glu
Phe Cys Cys Pro
Phe Cys Glu Ala
Phe Cys Pro Cys
Phe Asp Gly Met
Phe Asp Met Gly
Phe Glu Ala Cys
Phe Glu Cys Ala
Phe Gly Asp Met
Phe Gly Met Asp
Phe Met Asp Gly
Phe Met Gly Asp
Phe Pro Cys Cys
Gly Asp Asp Tyr
C19H24N4O10 (468.14923639999995)
Gly Asp Phe Met
Gly Asp Met Phe
Gly Asp Tyr Asp
C19H24N4O10 (468.14923639999995)
Gly Phe Asp Met
Gly Phe Met Asp
Gly Met Asp Phe
Gly Met Phe Asp
Gly Met Met Met
C17H32N4O5S3 (468.15347420000006)
Gly Tyr Asp Asp
C19H24N4O10 (468.14923639999995)
Ile Cys Cys Met
C17H32N4O5S3 (468.15347420000006)
Ile Cys Met Cys
C17H32N4O5S3 (468.15347420000006)
Ile Met Cys Cys
C17H32N4O5S3 (468.15347420000006)
Leu Cys Cys Met
C17H32N4O5S3 (468.15347420000006)
Leu Cys Met Cys
C17H32N4O5S3 (468.15347420000006)
Leu Met Cys Cys
C17H32N4O5S3 (468.15347420000006)
Met Cys Cys Ile
C17H32N4O5S3 (468.15347420000006)
Met Cys Cys Leu
C17H32N4O5S3 (468.15347420000006)
Met Cys Asp Thr
Met Cys Glu Ser
Met Cys Ile Cys
C17H32N4O5S3 (468.15347420000006)
Met Cys Leu Cys
C17H32N4O5S3 (468.15347420000006)
Met Cys Ser Glu
Met Cys Thr Asp
Met Asp Cys Thr
Met Asp Phe Gly
Met Asp Gly Phe
Met Asp Thr Cys
Met Glu Cys Ser
Met Glu Ser Cys
Met Phe Asp Gly
Met Phe Gly Asp
Met Gly Asp Phe
Met Gly Phe Asp
Met Gly Met Met
C17H32N4O5S3 (468.15347420000006)
Met Ile Cys Cys
C17H32N4O5S3 (468.15347420000006)
Met Leu Cys Cys
C17H32N4O5S3 (468.15347420000006)
Met Met Gly Met
C17H32N4O5S3 (468.15347420000006)
Met Met Met Gly
C17H32N4O5S3 (468.15347420000006)
Met Met Ser Thr
Met Met Thr Ser
Met Ser Cys Glu
Met Ser Glu Cys
Met Ser Met Thr
Met Ser Thr Met
Met Thr Cys Asp
Met Thr Asp Cys
Met Thr Met Ser
Met Thr Ser Met
Pro Cys Cys Phe
Pro Cys Phe Cys
Pro Cys Ser Tyr
Pro Cys Tyr Ser
Pro Phe Cys Cys
Pro Ser Cys Tyr
Pro Ser Tyr Cys
Pro Tyr Cys Ser
Pro Tyr Ser Cys
Ser Cys Glu Met
Ser Cys Met Glu
Ser Cys Pro Tyr
Ser Cys Tyr Pro
Ser Glu Cys Met
Ser Glu Met Cys
Ser Met Cys Glu
Ser Met Glu Cys
Ser Met Met Thr
Ser Met Thr Met
Ser Pro Cys Tyr
Ser Pro Tyr Cys
Ser Thr Met Met
Ser Tyr Cys Pro
Ser Tyr Pro Cys
Thr Cys Asp Met
Thr Cys Met Asp
Thr Asp Cys Met
Thr Asp Met Cys
Thr Met Cys Asp
Thr Met Asp Cys
Thr Met Met Ser
Thr Met Ser Met
Thr Ser Met Met
Tyr Cys Pro Ser
Tyr Cys Ser Pro
Tyr Asp Asp Gly
C19H24N4O10 (468.14923639999995)
Tyr Asp Gly Asp
C19H24N4O10 (468.14923639999995)
Tyr Gly Asp Asp
C19H24N4O10 (468.14923639999995)
Tyr Pro Cys Ser
Tyr Pro Ser Cys
Tyr Ser Cys Pro
Tyr Ser Pro Cys
HoPhe-Phe4Cl-OH
C24H21ClN2O6 (468.10880760000003)
Phe4Cl-HoPhe-OH
C24H21ClN2O6 (468.10880760000003)
Lactococcin
Dukunolide D
(2R,6R,7R)-Benzhydryl 7-benzamido-3-methylene-8-oxo-5-oxa-1-azabicyclo[4.2.0]octane-2-carboxylate
N-[(9H-Fluoren-9-ylmethoxy)carbonyl]glycylglycylglycylglycine
3,6-Diamino-10-methylacridinium chloride 3,6-acridinediamine (1:1 :1)
21-chloro-16α-methyl-17α-hydroxy-1,4,9(11)-pregnatriene-3,20-dione 17-(2-furoate)
C27H29ClO5 (468.17034140000004)
Benzyl [1-[4-[[(4-Fluorobenzyl)amino]carbonyl]-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl]-1-methylethyl]carbamate
C24H25FN4O5 (468.18088919999997)
Bis(1,3-dithian-2-ylmethyl) 1,6-hexanediylbiscarbamate
C18H32N2O4S4 (468.12448320000004)
1H-Benzo[d][1,2,3]triazol-1-yl 4-(5-(4-(pentyloxy)phenyl)isoxazol-3-yl)benzoate
4-Nitrophenyl2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-a-D-glucopyranoside
[(2R,3S,4R,5R,6S)-5-acetamido-3,4-diacetyloxy-6-(4-nitrophenoxy)oxan-2-yl]methyl acetate
TERT-BUTYL2-(4-(PYRIDIN-2-YL)BENZYL)HYDRAZINECARBOXYLATE
(1R)-1-C-(4-Chloro-3-{4-[(3S)-tetrahydro-3-furanyloxy]benzyl}phenyl)-D-glucitol
Methyl 1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-5-C-(hydroxymethyl)-alpha-D-xylo-hexopyranoside
Ferrocene,1,1-(1-methylethylidene)bis[ethyl-
C27H32Fe2 (468.12026519999995)
Miransertib HCl
Miransertib hydrochloride (ARQ-092 hydrochloride) is a potent, orally active, selective and allosteric Akt inhibitor with IC50s of 2.7 nM, 14 nM and 8.1 nM for Akt1, Akt2, Akt3, respectively. Miransertib hydrochloride is also a potent the AKT1-E17K mutant protein inhibitor and has the potential for PI3K/AKT-driven tumors and Proteus syndrome research[1]. Miransertib hydrochloride is effective against Leishmania[2].
6-methoxy-3,3-diphenylbenzo[h]indeno[2,1-f]chromen-13(3H)-one
n-Nonyl triphenylphosphonium bromide
C27H34BrP (468.15813540000005)
2-Nitrophenyl2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-a-D-glucopyranoside
(2R)-2-Deoxy-2-fluoro-2-methyluridine 3,5-dibenzoate
4-[(5-carbamoyl-o-tolyl)azo]-3-hydroxy-2-methyl-2-naphth-p-anisidide
(r)-(+)-2-diphenylphosphino-2-methoxy-1,1-binaphthyl
Mubritinib
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor
3-Pyridinesulfonamide, 5-(5-phenyl-4-((2-pyridinylmethyl)amino)-2-quinazolinyl)-
Fosmanogepix
COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C254 - Anti-Infective Agent > C514 - Antifungal Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Acriflavine neutral
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D007364 - Intercalating Agents D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent D004396 - Coloring Agents > D005456 - Fluorescent Dyes D000890 - Anti-Infective Agents
Parsaclisib hydrochloride
C20H23Cl2FN6O2 (468.12434899999994)
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2152 - Phosphatidylinositide 3-Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor
Nigrasin J
A trihydroxyflavone that is flavone substituted by hydroxy groups at positions 5, 7 and 4, a methoxy group at position 3 and a 6-hydroxy-2-methylhept-2-en-6-yl substituted tetrahydrofuran ring across positions 5 and 6. It has been isolated from Morus nigra.
1,4-Bis[(4-methoxy-2-methylphenyl)sulfonyl]-1,4-diazepane
1-[3-(3,5-Dinitrobenzoylamino)butyl]-2-methyl-1H-indole-3-carboxylic acid ethyl ester
N-({6-[(4-Cyanobenzyl)oxy]naphthalen-2-YL}sulfonyl)-D-glutamic acid
C23H20N2O7S (468.09911700000004)
5-hydroxy-4-(7-methoxy-1,1-dioxido-2H-1,2,4-benzothiadiazin-3-yl)-2-(3-methylbutyl)-6-phenylpyridazin-3(2H)-one
simfibrate
C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent > C98150 - Fibrate Antilipidemic Agent C - Cardiovascular system > C10 - Lipid modifying agents > C10A - Lipid modifying agents, plain > C10AB - Fibrates
6-(Furan-3-yl)-13-hydroxy-5,12,16,16-tetramethyl-7,10,17-trioxahexacyclo[13.3.3.01,15.02,12.05,11.09,11]henicos-19-ene-8,14,21-trione
(2S)-2-[[2-[2-oxo-1-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-3H-indol-3-yl]acetyl]amino]butanedioic acid
(2S,13R,14R,16S,19S,20S)-19-(furan-3-yl)-9,9,13,20-tetramethyl-6,8,15,18-tetraoxahexacyclo[11.9.0.02,7.02,10.014,16.014,20]docos-3-ene-5,12,17-trione
3-(2,5-dimethoxyphenyl)-6-[4-methoxy-3-(3-oxolanyloxy)phenyl]-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine
2-[[2-(3,4-dimethoxyphenyl)-5-methyl-4-oxazolyl]methylsulfinyl]-N-(1,2,3,4-tetrahydronaphthalen-1-yl)acetamide
C25H28N2O5S (468.17188380000005)
N-(3-methylbutyl)-6-(4-morpholinylsulfonyl)-2-pyridin-4-yl-4-quinolinecarboxamide
C24H28N4O4S (468.18311680000005)
[4-(2,3-Dimethylphenyl)-1-piperazinyl]-[5-[(4-methoxyphenyl)sulfonylmethyl]-2-furanyl]methanone
C25H28N2O5S (468.17188380000005)
N-[[1-(2-methylpropyl)-2-oxo-3-indolylidene]amino]-3-(1-piperidinylsulfonyl)benzamide
C24H28N4O4S (468.18311680000005)
3-[(2-chlorophenyl)methyl]-5-[1-(1-oxo-2-thiophen-2-ylethyl)-4-piperidinyl]-2H-triazolo[4,5-d]pyrimidin-7-one
2-[[1-oxo-2-(2-pyrimidinylthio)ethyl]amino]-6-(phenylmethyl)-5,7-dihydro-4H-thieno[2,3-c]pyridine-3-carboxylic acid ethyl ester
2-amino-N-(3-ethoxypropyl)-1-(4-sulfamoylphenyl)-3-pyrrolo[3,2-b]quinoxalinecarboxamide
diethyl 5-[[2-(furan-2-carbonylamino)benzoyl]oxymethyl]-3-methyl-1H-pyrrole-2,4-dicarboxylate
C24H24N2O8 (468.15325839999997)
N-Cyclohexyl-2-(4-fluoro-phenyl)-2-[(4-fluoro-phenyl)-(2-thiophen-3-yl-acetyl)-amino]-acetamide
(2Z)-2-[3-[2-[4-(benzenesulfonyl)piperazin-1-yl]-2-oxoethyl]-4-oxo-1,3-benzothiazin-2-ylidene]acetonitrile
1-{3-[3-(2-Chloro-benzyl)-7-hydroxy-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-yl]-piperidin-1-yl}-2-thiophen-2-yl-ethanone
2-[[(6-ethyl-4-oxo-3-prop-2-enyl-2-thieno[2,3-d]pyrimidinyl)thio]methyl]-4-oxo-1H-quinazoline-7-carboxylic acid methyl ester
2-[[3-[2-(dimethylamino)ethyl]-4-oxo-[1]benzothiolo[3,2-d]pyrimidin-2-yl]thio]-N-(3-methoxyphenyl)acetamide
N-[(2S,3R,6R)-6-[2-[4-(2-fluorophenyl)triazol-1-yl]ethyl]-2-(hydroxymethyl)oxan-3-yl]-1,3-benzodioxole-5-carboxamide
C24H25FN4O5 (468.18088919999997)
N-[(2S,3S)-4-[(2-chlorophenyl)methyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methylbenzenesulfonamide
C23H33ClN2O4S (468.1849448000001)
N-[(2R,3R,6S)-6-[2-[4-(2-fluorophenyl)triazol-1-yl]ethyl]-2-(hydroxymethyl)oxan-3-yl]-1,3-benzodioxole-5-carboxamide
C24H25FN4O5 (468.18088919999997)
N-[(2S,3R)-4-[(4-fluorophenyl)sulfonyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methyl-2-pyrazinecarboxamide
N-[(2S,3R)-4-[(4-fluorophenyl)sulfonyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methylpyrazine-2-carboxamide
N-[(2S,3S)-4-[(4-fluorophenyl)sulfonyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methylpyrazine-2-carboxamide
N-[(2S,3R)-4-[(2-chlorophenyl)methyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methylbenzenesulfonamide
C23H33ClN2O4S (468.1849448000001)
N-[(2S,3R)-4-[(2-chlorophenyl)methyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methylbenzenesulfonamide
C23H33ClN2O4S (468.1849448000001)
N-[(2R,3R)-4-[(2-chlorophenyl)methyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methylbenzenesulfonamide
C23H33ClN2O4S (468.1849448000001)
N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-1,3-benzothiazole-2-carboxamide
C24H28N4O4S (468.18311680000005)
N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-1,3-benzothiazole-2-carboxamide
C24H28N4O4S (468.18311680000005)
N-[(2S,3R,6S)-6-[2-[4-(2-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-1,3-benzodioxole-5-carboxamide
C24H25FN4O5 (468.18088919999997)
N-[(2S,3S,6R)-6-[2-[4-(2-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-1,3-benzodioxole-5-carboxamide
C24H25FN4O5 (468.18088919999997)
N-[(2R,3S)-4-[(4-fluorophenyl)sulfonyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methyl-2-pyrazinecarboxamide
N-[(2R,3R)-4-[(4-fluorophenyl)sulfonyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methyl-2-pyrazinecarboxamide
N-[(2R,3S)-4-[(4-fluorophenyl)sulfonyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methyl-2-pyrazinecarboxamide
N-[(2R,3R)-4-[(4-fluorophenyl)sulfonyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methyl-2-pyrazinecarboxamide
N-[(2R,3S)-4-[(2-chlorophenyl)methyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methylbenzenesulfonamide
C23H33ClN2O4S (468.1849448000001)
[(3aS,4R,9bS)-1-(3-fluorophenyl)sulfonyl-8-(2-methoxyphenyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-4-yl]methanol
N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-1,3-benzothiazole-2-carboxamide
C24H28N4O4S (468.18311680000005)
N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-1,3-benzothiazole-2-carboxamide
C24H28N4O4S (468.18311680000005)
N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-1,3-benzothiazole-2-carboxamide
C24H28N4O4S (468.18311680000005)
N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-1,3-benzothiazole-2-carboxamide
C24H28N4O4S (468.18311680000005)
N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-1,3-benzothiazole-2-carboxamide
C24H28N4O4S (468.18311680000005)
N-[(2R,3S,6R)-6-[2-[4-(2-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-1,3-benzodioxole-5-carboxamide
C24H25FN4O5 (468.18088919999997)
N-[(2R,3S,6S)-6-[2-[4-(2-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-1,3-benzodioxole-5-carboxamide
C24H25FN4O5 (468.18088919999997)
N-[(2S,3S)-4-[(4-fluorophenyl)sulfonyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methyl-2-pyrazinecarboxamide
N-[(2R,3R)-4-[(2-chlorophenyl)methyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methylbenzenesulfonamide
C23H33ClN2O4S (468.1849448000001)
N-[(2S,3S)-4-[(2-chlorophenyl)methyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methylbenzenesulfonamide
C23H33ClN2O4S (468.1849448000001)
N-[(2R,3S)-4-[(2-chlorophenyl)methyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methylbenzenesulfonamide
C23H33ClN2O4S (468.1849448000001)
[(3aR,4S,9bR)-1-(3-fluorophenyl)sulfonyl-8-(2-methoxyphenyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-4-yl]methanol
1-(6-Methylpyridin-2-yl)-5-(3-phenoxyphenyl)-4-(thiophene-2-carbonyl)pyrrolidine-2,3-dione
C27H20N2O4S (468.11437200000006)
(1R,2R,5S,6S,7S)-2-(Benzylcarbamoyl)-3-[3-chloro-2-(hydroxymethyl)phenyl]-4-oxo-10-oxa-3-azatricyclo[5.2.1.01,5]dec-8-ene-6-carboxylic acid
C24H21ClN2O6 (468.10880760000003)
2,2,5,5,7,7,10,10,12,12,15,15-Dodecamethyl-1,6,11-trioxa-2,5,7,10,12,15-hexasila-3,8,13-cyclopentadecatriyne
C18H36O3Si6 (468.12799860000007)
2-(4-Hydroxyphenyl)ethyl 2,3,4,6-tetra-O-acetyl-alpha-(D)-glucopyranoside
C22H28O11 (468.16315380000003)
(3R)-9-[(2R,4R,5S,6R)-4,5-dihydroxy-6-methyl-tetrahydropyran-2-yl]-3,5,8-trihydroxy-3-methyl-2,4-dihydrobenzo[a]anthracene-1,7,12-trione
(3R)-9-[(2R,4R,5S,6R)-4,5-dihydroxy-6-methyl-tetrahydropyran-2-yl]-3,6,8-trihydroxy-3-methyl-2,4-dihydrobenzo[a]anthracene-1,7,12-trione
TAE226(NVP-TAE226)
C23H25ClN6O3 (468.16765699999996)
2-[3-[2-[4-(benzenesulfonyl)-1-piperazinyl]-2-oxoethyl]-4-oxo-1,3-benzothiazin-2-ylidene]acetonitrile
Lp-PLA2-IN-1
C21H17F5N4O3 (468.1220751999999)
Lp-PLA2-IN-1 is a potent Lipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitor. Lp-PLA2-IN-1 has the potential for atherosclerosis, Alzheimer's disease research[1].
SRT 2183
SRT 2183 is a selective Sirtuin-1 (SIRT1) activator with an EC1.5 value of 0.36 μM[1]. SRT 2183 induces growth arrest and apoptosis, concomitant with deacetylation of STAT3 and NF-κB, and reduction of c-Myc protein levels[2].
5-{2-[8-hydroxy-3-(4-hydroxy-3,5-dimethoxyphenyl)-2-(hydroxymethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]ethenyl}benzene-1,3-diol
2-(4-hydroxy-3,5-dimethoxyphenyl)-5-methoxy-3-methyl-8-(2-methylbut-3-en-2-yl)-2h,3h-[1,4]dioxino[2,3-h]chromen-9-one
(4r,5r,14r)-14-(3,4-dihydroxyphenyl)-5,8-dihydroxy-4-(3,4,5-trihydroxyphenyl)-3,11-dioxatricyclo[8.4.0.0²,⁷]tetradeca-1(10),2(7),8-trien-12-one
(3s)-6-hydroxy-3-methyl-8-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-3,4-dihydro-2h-tetraphene-1,7,12-trione
[(2r,3s,4s,5r,6r)-6-[2-(3,4-dihydroxyphenyl)ethoxy]-3,4,5-trihydroxyoxan-2-yl]methyl 3,4,5-trihydroxybenzoate
4-hydroxy-19-methoxy-2,15-dioxapentacyclo[22.2.2.1³,⁷.1¹⁰,¹⁴.0¹⁶,²¹]triaconta-1(26),3(30),4,6,10,12,14(29),16(21),18,24,27-undecaene-17,20-dione
(2e)-3-[5-(acetyloxy)-2-{3-[4-(acetyloxy)-3-methoxyphenyl]prop-1-en-2-yl}-4-methoxyphenyl]prop-2-en-1-yl acetate
(1's,2r,5's,6'r,12's)-7,12',14-trihydroxy-5'-methoxy-3,4',8',10-tetraoxaspiro[tetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadecane-2,3'-tricyclo[4.3.3.0¹,⁶]dodecane]-1(14),4,6,8(16),11(15),12-hexaene-9,9'-dione
2-(2,5-dihydroxy-4-methoxyphenyl)-5,7-dihydroxy-3-(1-hydroxy-3-methylbut-2-en-1-yl)-8-(3-methylbut-2-en-1-yl)chromen-4-one
4-hydroxy-3-methyl-8-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]-3,4-dihydro-2h-tetraphene-1,7,12-trione
(2s,3s,4s,5r,6s)-3,4,5-trihydroxy-6-({5-methoxy-4-phenyl-[1,1'-biphenyl]-6-yl}oxy)oxane-2-carboxylic acid
[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-[2-hydroxy-5-(2-hydroxyethyl)phenoxy]oxan-2-yl]methyl 3,4,5-trihydroxybenzoate
(9s)-9-(2-hydroperoxypropan-2-yl)-5,14-dihydroxy-16-methoxy-15-[(1e)-3-methylbut-1-en-1-yl]-8,19-dioxatetracyclo[9.8.0.0²,⁷.0¹³,¹⁸]nonadeca-1(11),2,4,6,13,15,17-heptaen-12-one
(1s,4ar,5r,7s,7as)-7-hydroxy-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-5-yl 4-hydroxybenzoate
C22H28O11 (468.16315380000003)